Contribution of large genomic rearrangements in to familial breast cancer: implications for genetic testing.

Background: is the most important contributor to familial breast cancer after and . Large genomic rearrangements (LGRs) in and are routinely assessed in clinical testing and are a significant contributor to the yield of actionable findings. In contrast, the contribution of LGRs in has not been systematically studied.